- Experimental anti-amyloid treatment started before Alzheimer’s symptoms slowed memory lossNeuroscience News
- Solanezumab, Eli Lilly’s Alzheimer’s treatment, failed to slow disease progressionCNBC
- Pharmalittle: Pharmacies are battlegrounds in the abortion debate; Lilly Alzheimer’s drug failed to prevent memory loss in studySTAT
- Lilly’s 10-year bet on treating Alzheimer’s before symptoms start ends in failureFierceBiotech
- Eli Lilly Stock: A decade-long effort to treat Alzheimer’s disease fails | Investor Business DailyInvestor Business Daily